Ginkgo Bioworks Holdings Inc (DNA)
8.09
+0.39
(+5.06%)
USD |
NYSE |
Sep 27, 16:00
8.10
+0.01
(+0.12%)
Pre-Market: 20:00
Ginkgo Bioworks Holdings Revenue (Annual): 251.46M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 251.46M |
December 31, 2022 | 477.71M |
December 31, 2021 | 313.84M |
Date | Value |
---|---|
December 31, 2020 | 76.66M |
December 31, 2019 | 54.18M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
54.18M
Minimum
2019
477.71M
Maximum
2022
234.77M
Average
251.46M
Median
2023
Revenue (Annual) Benchmarks
Boston Scientific Corp | 14.24B |
UnitedHealth Group Inc | 367.53B |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.202M |
IGC Pharma Inc | 1.345M |